3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Vipoma
1
Somatostatinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Insulinoma
1
Glucagonoma
1
Gastrinoma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Islet Cell
1
Adenoma, Islet Cell
1
Interventions
fludarabine phosphate
19
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
15
Mycophenolic Acid
15
Tacrolimus
12
Cyclosporine
11
Cyclophosphamide
11
Antilymphocyte Serum
11
Busulfan
10
Rituximab
7
Methotrexate
7
Etoposide
6
Melphalan
5
Flow Cytometry
5
Radiotherapy
4
Panobinostat
4
Lenalidomide
4
Filgrastim
4
Everolimus
4
Dexamethasone
4
Calcium Dobesilate
4
thymoglobulin
3
romidepsin
3
pembrolizumab
3
mogamulizumab
3
fludarabine
3
Therapeutics
3
Sirolimus
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sezary Syndrome
×
motesanib diphosphate
×
Clear all
No trials found.